5fnc
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Dynamic Undocking and the Quasi-Bound State as tools for Drug Design== | ==Dynamic Undocking and the Quasi-Bound State as tools for Drug Design== | ||
| - | <StructureSection load='5fnc' size='340' side='right' caption='[[5fnc]], [[Resolution|resolution]] 2.20Å' scene=''> | + | <StructureSection load='5fnc' size='340' side='right'caption='[[5fnc]], [[Resolution|resolution]] 2.20Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5fnc]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FNC OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5fnc]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5FNC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5FNC FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=IEE:6-CHLORO-4-N-[(4-METHYLPHENYL)METHYL]PYRIMIDINE-+2,4-DIAMINE'>IEE</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.2Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IEE:6-CHLORO-4-N-[(4-METHYLPHENYL)METHYL]PYRIMIDINE-+2,4-DIAMINE'>IEE</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5fnc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5fnc OCA], [https://pdbe.org/5fnc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5fnc RCSB], [https://www.ebi.ac.uk/pdbsum/5fnc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5fnc ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/HS90A_HUMAN HS90A_HUMAN] Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function.<ref>PMID:15937123</ref> <ref>PMID:11274138</ref> |
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | There is a pressing need for new technologies that improve the efficacy and efficiency of drug discovery. Structure-based methods have contributed towards this goal but they focus on predicting the binding affinity of protein-ligand complexes, which is notoriously difficult. We adopt an alternative approach that evaluates structural, rather than thermodynamic, stability. As bioactive molecules present a static binding mode, we devised dynamic undocking (DUck), a fast computational method to calculate the work necessary to reach a quasi-bound state at which the ligand has just broken the most important native contact with the receptor. This non-equilibrium property is surprisingly effective in virtual screening because true ligands form more-resilient interactions than decoys. Notably, DUck is orthogonal to docking and other 'thermodynamic' methods. We demonstrate the potential of the docking-undocking combination in a fragment screening against the molecular chaperone and oncology target Hsp90, for which we obtain novel chemotypes and a hit rate that approaches 40%. | ||
| + | |||
| + | Dynamic undocking and the quasi-bound state as tools for drug discovery.,Ruiz-Carmona S, Schmidtke P, Luque FJ, Baker L, Matassova N, Davis B, Roughley S, Murray J, Hubbard R, Barril X Nat Chem. 2017 Mar;9(3):201-206. doi: 10.1038/nchem.2660. Epub 2016 Nov 14. PMID:28221352<ref>PMID:28221352</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 5fnc" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Heat Shock Protein structures|Heat Shock Protein structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Baker | + | [[Category: Homo sapiens]] |
| - | [[Category: Barril | + | [[Category: Large Structures]] |
| - | [[Category: Davis | + | [[Category: Baker LM]] |
| - | [[Category: Hubbard | + | [[Category: Barril X]] |
| - | [[Category: Luque | + | [[Category: Davis B]] |
| - | [[Category: Matassova | + | [[Category: Hubbard R]] |
| - | [[Category: Murray | + | [[Category: Luque FJ]] |
| - | [[Category: Roughley | + | [[Category: Matassova N]] |
| - | [[Category: Ruiz-Carmona | + | [[Category: Murray J]] |
| - | [[Category: Schmidtke | + | [[Category: Roughley S]] |
| - | + | [[Category: Ruiz-Carmona S]] | |
| - | + | [[Category: Schmidtke P]] | |
| - | + | ||
| - | + | ||
Current revision
Dynamic Undocking and the Quasi-Bound State as tools for Drug Design
| |||||||||||
Categories: Homo sapiens | Large Structures | Baker LM | Barril X | Davis B | Hubbard R | Luque FJ | Matassova N | Murray J | Roughley S | Ruiz-Carmona S | Schmidtke P
